Heart Disease News and Research

Latest Heart Disease News and Research

AACN to honor Seattle nurse with Flame of Excellence Award

The American Association of Critical-Care Nurses (AACN) will present the Flame of Excellence Award to Carol Jacobson, RN, MN, for her efforts to educate progressive care and critical care nurses in the care of patients with cardiac disease.

19 May 2012

Personal genetic test results does not drive overuse of expensive medical care

People have increasing opportunities to participate in genetic testing that can indicate their range of risk for developing a disease. Receiving these results does not appreciably drive up or diminish test recipients' demand for potentially costly follow-up health services, according to a study performed by researchers at the National Institutes of Health and colleagues at other institutions.

19 May 2012

UK-led technologies set to transform treatments on the NHS

Video games, pioneering gene therapies and new medical devices are set to transform treatments on the NHS, with support from the Department of Health and the Wellcome Trust.

19 May 2012

Rare DNA variations may be responsible for differences in susceptibility to common disorders

One-letter switches in the DNA code occur much more frequently in human genomes than anticipated, but are often only found in one or a few individuals. The abundance of rare variations across the human genome is consistent with the population explosion of the past few thousand years, medical geneticists and evolutionary biologists report in the May 17 advanced online edition of Science.

19 May 2012

Exercise could reduce risk of asthma symptoms or attacks

Not only is it safe for people with asthma to exercise, but doing so could reduce their risk of asthma symptoms or attacks, according to a new evidence review in The Cochrane Library.

19 May 2012

Sigmoid provides financial and product development update

Sigmoid Pharma Ltd., a privately-owned, specialty pharmaceutical and drug delivery company registered in Ireland, today provides an update on significant progress in 2011 and 2012.

19 May 2012

Urocortin 2 improves cardiac output in Phase II study for acute decompensated heart failure

Neurocrine Biosciences, Inc. today announced efficacy and safety results from a Phase II trial of urocortin 2 in 53 patients with acute decompensated heart failure. The UNICORN study was conducted over approximately a two year period by the Cardioendocrine Research Group from the University of Otago in Christchurch, New Zealand and included patients admitted to Christchurch Hospital with acute decompensated heart failure.

18 May 2012

Personal genetic test results don't drive overuse of expensive medical care

People have more and more chances to participate in genetic testing that can indicate their range of risk for developing a disease. Receiving these results does not appreciably drive up- or diminish-test recipients' demand for potentially costly follow-up health services, according to a new study in the May 17, 2012 early online issue of Genetics in Medicine.

18 May 2012

First Edition: May 18, 2012

Today's headlines include a report that congressional conservatives are fighting amongst themselves over health law strategies.

18 May 2012

The truth about chocolate: does it really contain flavonoids?

There have been many news stories over the years about chocolate and whether it is good or bad for you. The stories often comment on a chemical constituent of chocolate: flavonoids. But what are flavonoids? Does chocolate even contain them? And why should we care if it does?

18 May 2012

Regular eating times, extended daily fasting may prevent diabetes, obesity

It turns out that when we eat may be as important as what we eat. Scientists at the Salk Institute for Biological Studies have found that regular eating times and extending the daily fasting period may override the adverse health effects of a high-fat diet and prevent obesity, diabetes and liver disease in mice.

18 May 2012

Medtronic announces new results from CoreValve ADVANCE Study

Medtronic, Inc. today announced new results from the Medtronic CoreValve ADVANCE Study, which found that women and men benefitted similarly from the Medtronic CoreValve System.

From Medtronic 18 May 2012

Longer looks: Music as a means of treatment for PTSD

On one of the many days Leo Dunson wanted to die, the Iraq veteran put a gun to his temple and pulled the trigger. The loaded weapon misfired. For the troubled former soldier, it was another inexplicable failure, like his divorce or inability to make friends after returning from the war. In a Las Vegas recording studio, Dunson rapped about his life: "What's wrong with me? Got PTSD. These pills ain't working, man, I still can't think."

18 May 2012

Patients with morbid obesity more likely to develop complications after spinal fusion surgery

Patients with morbid obesity are at nearly twice the risk of developing complications after spinal fusion surgery, reports a study in the May 15 issue of Spine.

18 May 2012

One type of open heart surgery is likely safer than the other for CKD patients

One type of open heart surgery is likely safer than the other for chronic kidney disease (CKD) patients, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

18 May 2012

Researchers develop Bluetooth fetal heart rate monitoring system

Checking the heart of the unborn baby usually involves a stethoscope. However, an inexpensive and accurate Bluetooth fetal heart rate monitoring system has now been developed by researchers in India for long-term home care.

18 May 2012

Renal denervation can effectively reduce blood pressure in CKD patients with hypertension

Disrupting certain nerves in the kidneys can safely and effectively lower blood pressure in patients with chronic kidney disease (CKD) and hypertension, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.

18 May 2012

Boston Scientific launches Epic Vascular Self-Expanding Stent System

Boston Scientific Corporation announces U.S. Food and Drug Administration approval and market launch of the Epic Vascular Self-Expanding Stent System.

18 May 2012

UHN chooses Lexicomp as drug information resource for four hospitals

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Lexicomp has been selected by the University Health Network (UHN) as the drug information resource for its four hospitals located in Toronto, Canada.

18 May 2012

Spectrum initiates ZEVALIN and MGd Phase 2 combination study in NHL

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the initiation of a Phase 2 study evaluating ZEVALIN (ibritumomab tiuxetan) Injection for intravenous use + rituximab in combination with motexafin gadolinium (MGd) in patients with rituximab-refractory low-grade or follicular B-cell non-Hodgkin's lymphoma.

18 May 2012